Montag & Associates’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.21M | Sell |
50,191
-88
| -0.2% | -$2.3K | 0.05% | 228 |
|
|
2026
Q1 | $1.41M | Sell |
50,279
-2,402
| -5% | -$63.9K | 0.07% | 207 |
|
|
2025
Q4 | $1.31M | Sell |
52,681
-470
| -0.9% | -$11.9K | 0.06% | 205 |
|
|
2025
Q3 | $1.35M | Sell |
53,151
-9,159
| -15% | -$226K | 0.06% | 204 |
|
|
2025
Q2 | $1.51M | Sell |
62,310
-4,884
| -7% | -$114K | 0.07% | 193 |
|
|
2025
Q1 | $1.7M | Sell |
67,194
-8,468
| -11% | -$222K | 0.09% | 181 |
|
|
2024
Q4 | $2.01M | Sell |
75,662
-4,810
| -6% | -$130K | 0.1% | 169 |
|
|
2024
Q3 | $2.33M | Sell |
80,472
-679
| -0.8% | -$19.8K | 0.11% | 167 |
|
|
2024
Q2 | $2.27M | Sell |
81,151
-7,641
| -9% | -$210K | 0.11% | 151 |
|
|
2024
Q1 | $2.46M | Sell |
88,792
-23,977
| -21% | -$665K | 0.12% | 154 |
|
|
2023
Q4 | $3.25M | Sell |
112,769
-2,430
| -2% | -$73.5K | 0.18% | 120 |
|
|
2023
Q3 | $3.82M | Sell |
115,199
-8,695
| -7% | -$307K | 0.24% | 92 |
|
|
2023
Q2 | $4.54M | Buy |
123,894
+726
| +0.6% | +$28.3K | 0.28% | 84 |
|
|
2023
Q1 | $5.03M | Buy |
123,168
+1,903
| +2% | +$82.2K | 0.33% | 78 |
|
|
2022
Q4 | $6.21M | Sell |
121,265
-2,345
| -2% | -$112K | 0.42% | 64 |
|
|
2022
Q3 | $5.41M | Buy |
123,610
+1,296
| +1% | +$63K | 0.37% | 73 |
|
|
2022
Q2 | $6.41M | Sell |
122,314
-1,620
| -1% | -$82.6K | 0.41% | 62 |
|
|
2022
Q1 | $6.42M | Sell |
123,934
-614
| -0.5% | -$31.9K | 0.34% | 80 |
|
|
2021
Q4 | $7.36M | Sell |
124,548
-6,137
| -5% | -$304K | 0.36% | 79 |
|
|
2021
Q3 | $5.62M | Sell |
130,685
-6,463
| -5% | -$286K | 0.3% | 91 |
|
|
2021
Q2 | $5.37M | Buy |
137,148
+187
| +0.1% | +$7.27K | 0.29% | 95 |
|
|
2021
Q1 | $4.96M | Sell |
136,961
-7,428
| -5% | -$264K | 0.28% | 102 |
|
|
2020
Q4 | $5.32M | Sell |
144,389
-3,837
| -3% | -$141K | 0.33% | 81 |
|
|
2020
Q3 | $5.16M | Sell |
148,226
-2,187
| -1% | -$76.7K | 0.42% | 69 |
|
|
2020
Q2 | $4.67M | Sell |
150,413
-485
| -0.3% | -$16.5K | 0.41% | 71 |
|
|
2020
Q1 | $4.67M | Sell |
150,898
-7,504
| -5% | -$256K | 0.47% | 62 |
|
|
2019
Q4 | $5.89M | Sell |
158,402
-5,873
| -4% | -$209K | 0.47% | 58 |
|
|
2019
Q3 | $5.6M | Sell |
164,275
-38,010
| -19% | -$1.38M | 0.49% | 54 |
|
|
2019
Q2 | $8.31M | Sell |
202,285
-7,641
| -4% | -$303K | 0.74% | 38 |
|
|
2019
Q1 | $8.46M | Sell |
209,926
-12,657
| -6% | -$507K | 0.78% | 33 |
|
|
2018
Q4 | $9.22M | Sell |
222,583
-803
| -0.4% | -$33.3K | 0.99% | 25 |
|
|
2018
Q3 | $9.34M | Buy |
223,386
+20,035
| +10% | +$771K | 0.82% | 31 |
|
|
2018
Q2 | $7M | Buy |
203,351
+3,439
| +2% | +$118K | 0.72% | 35 |
|
|
2018
Q1 | $6.73M | Buy |
199,912
+2,322
| +1% | +$79.8K | 0.69% | 38 |
|
|
2017
Q4 | $6.79M | Sell |
197,590
-3,572
| -2% | -$122K | 0.66% | 41 |
|
|
2017
Q3 | $6.81M | Sell |
201,162
-1,878
| -0.9% | -$60.4K | 0.73% | 35 |
|
|
2017
Q2 | $6.47M | Buy |
203,040
+5,953
| +3% | +$188K | 0.73% | 40 |
|
|
2017
Q1 | $6.4M | Sell |
197,087
-4,285
| -2% | -$135K | 0.72% | 42 |
|
|
2016
Q4 | $6.21M | Buy |
201,372
+2,431
| +1% | +$74.2K | 0.73% | 40 |
|
|
2016
Q3 | $6.39M | Buy |
198,941
+1,848
| +0.9% | +$61.8K | 0.81% | 33 |
|
|
2016
Q2 | $6.58M | Buy |
197,093
+316
| +0.2% | +$10.1K | 0.87% | 32 |
|
|
2016
Q1 | $5.53M | Sell |
196,777
-6,588
| -3% | -$188K | 0.78% | 34 |
|
|
2015
Q4 | $6.23M | Buy |
203,365
+1,850
| +0.9% | +$58.2K | 0.91% | 26 |
|
|
2015
Q3 | $6M | Buy |
201,515
+10,013
| +5% | +$321K | 0.94% | 29 |
|
|
2015
Q2 | $6.09M | Sell |
191,502
-3,408
| -2% | -$111K | 0.89% | 34 |
|
|
2015
Q1 | $6.43M | Sell |
194,910
-3,124
| -2% | -$99.3K | 0.93% | 27 |
|
|
2014
Q4 | $5.85M | Buy |
198,034
+4,321
| +2% | +$124K | 0.88% | 34 |
|
|
2014
Q3 | $5.43M | Sell |
193,713
-2,161
| -1% | -$60.6K | 0.9% | 31 |
|
|
2014
Q2 | $5.52M | Sell |
195,874
-68,630
| -26% | -$1.96M | 0.9% | 32 |
|
|
2014
Q1 | $8.06M | Sell |
264,504
-15,879
| -6% | -$473K | 1.36% | 14 |
|
|
2013
Q4 | $8.15M | Buy |
280,383
+4,601
| +2% | +$134K | 1.4% | 15 |
|
|
2013
Q3 | $7.52M | Buy |
275,782
+6,958
| +3% | +$189K | 1.4% | 14 |
|
|
2013
Q2 | $7.14M | Buy |
+268,824
| New | +$7.43M | 1.46% | 9 |
|
Other funds holding PFE
Montag & Associates's PFE Position: Q2 2026 in Review
Montag & Associates reduced its Pfizer (PFE) stake by 0.18% in Q2 2026, selling an estimated $2.3K and leaving 50,191 shares worth $1.21M. The position accounts for 0.05% of the portfolio, ranked #228.
Montag & Associates first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $9.34M in Q3 2018. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Montag & Associates held 50,191 shares of Pfizer worth $1.21M as of Q2 2026.
- Montag & Associates sold 88 Pfizer shares in Q2 2026, an estimated $2.3K.
- Pfizer made up 0.05% of Montag & Associates's portfolio in Q2 2026, its #228 holding.
- Montag & Associates first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Montag & Associates's Pfizer position peaked at $9.34M in Q3 2018.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Montag & Associates's 13F filing for Q2 2026, filed 5 Aug 2026.